The lay media often cast the screening mammo debate in black and white terms. It’s a disservice; breast imagers and physicians realize the issues are far more nuanced. Women’s right to screening is a highly emotionally charged issue, further complicating physicians’ attempts to educate women and often derailing stakeholders’ calls for targeted screening. Peggy Orenstein completed an incredibly detailed review of the risks and benefits of screening and treatment and the role of nonprofit marketing in an article published April 26 in The New York Times magazine. Check it out, and please consider sharing it.